BL-1249
SIGMA/B2186 - ≥98% (HPLC)
Synonym: (5,6,7,8-
CAS Number: 18200-13-0
Empirical Formula (Hill Notation): C17H17N5
Molecular Weight: 291.35
MDL Number: MFCD08276915
Linear Formula: C17H17N5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | pink to brown |
| form | solid |
| InChI | 1S/C17H17N5/c1-2-8-13-12( |
| InChI key | YYNRZIFBTOUICE-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | C1CCc2c(C1)cccc2Nc3ccccc3 |
| solubility | DMSO: ~17.5 mg/mL |
| H2O: insoluble | |
| storage condition | protect from light |
| storage temp. | −20°C |
| Application: | BL-1249 has been used: • as an activator of mechano-gated K2P channel in contracted mouse ileum and colon tissues • as a TWIK related potassium channel (TREK2) modulator and in U-2 OS osteosarcoma cell line • as a TREK1 and TREK2 activator in mice. |
| Biochem/physiol Actions: | BL-1249 also activates TWIK related potassium channel 2 (TREK2). It interacts with K2P channel at the negatively charged activator site and modulates channel opening. |
| Biochem/physiol Actions: | BL-1249 is a potassium TREK-1 channel activator. |
| Biochem/physiol Actions: | BL-1249 is a putative activator of potassium TREK-1 channel. |
| Features and Benefits: | This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| General description: | BL-1249 is a non-steroid anti-inflammatory drug and an inhibitor of the cyclooxygenase (COX) enzyme. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 - H413 |
| Precautionary statements | P273 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


